secwatch / observer
8-K filed July 15, 2025, 7:59 PM ET ticker BNKK CIK 0001760903
other material confidence high sentiment negative materiality 0.70

BONK, INC. (BNKK): Nasdaq/NYSE listing notice — Safety Shot sells 500K SRM shares for $3.125M; Nasdaq gives bid-price extension to Dec 29, 2025

BONK, INC.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

BONK, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

Exchange
nasdaq
Notice
extension granted
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
isting Rule 5550(a)(2) (“Rule 5550(a)(2)”). Nasdaq’s Notice has no immediate effect on the listing or trading of our
View on SEC.gov
Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

BONK, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
January 2, 2025, Safety Shot, Inc., (the “Company”) received a notice from The Nasdaq Stock Exchange (“Nasdaq”) that the closing bid price for our common stock had been below $1.00 per share for the previous 30 consecutive days, and that we are therefore not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). Nasdaq’s Notice has no immediate effect on the listing or trading of our common stock on the Nasdaq Capital Market. On July 9, 2025, the Company received a notification (the “Ex
View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

BONK, INC. filing history →

Source: SEC EDGAR
accession 0001641172-25-019748
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.